- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Roxana Siles: Blinded Trials Are Important When Evaluating Chronic Cough Treatment
Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic, addresses the placebo effect seen in clinical trials of chronic cough treatment.
Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic, addresses why a placebo effect is often seen in clinical trials investigating the impact of chronic cough treatment and how this is addressed.
Transcript
How might the placebo effect impact in clinical trials for chronic cough treatment be overcome when testing a medication’s effectiveness?
The placebo effect is real, and it’s not uncommon for patients who enter clinical trials for treatment of cough that they go through rigorous evaluation and they really maximize the therapy. One thing that’s common in trials is that patients tend to be perhaps more adherent to the regimen because they are in trials and perhaps they’re being monitored more closely. So yes, it can be tricky. But certainly, this is why we have blinded, placebo-controlled [trials], because they will tell us whether or not an effective treatment despite having that placebo benefit is even that much more effective when it comes to statistical data and finding that it is a good comparison.
Care Quality Metrics in Medicare During COVID-19 Pandemic
August 12th 2025Medicare Advantage outperformed traditional Medicare on clinical quality measures before and during the COVID-19 pandemic; mid-pandemic, however, traditional Medicare narrowed the gap on some in-person screenings.
Read More
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
Accessing pediatric dermatology care is challenging due to a shortage of specialists and general dermatologists' reluctance to treat children, but increasing their comfort level with seeing children could help bridge the gap, explained Elizabeth Garcia Creighton, of University of Colorado School of Medicine.
Read More
Exploring the Potential of Machine Learning in Optimizing Respiratory Failure Treatment
August 9th 2025Machine learning holds promise for optimizing treatment strategies and potentially improving outcomes in respiratory failure but future research and development are necessary to fully realize its potential in clinical practice.
Read More
